Titre : Dose létale 50

Dose létale 50 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Computer Security
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Dose létale 50 : Questions médicales les plus fréquentes", "headline": "Dose létale 50 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Dose létale 50 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-21", "dateModified": "2025-04-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Dose létale 50" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Relation dose-effet des médicaments", "url": "https://questionsmedicales.fr/mesh/D004305", "about": { "@type": "MedicalCondition", "name": "Relation dose-effet des médicaments", "code": { "@type": "MedicalCode", "code": "D004305", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G07.690.936.500" } } }, "about": { "@type": "MedicalCondition", "name": "Dose létale 50", "alternateName": "Lethal Dose 50", "code": { "@type": "MedicalCode", "code": "D007928", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xia Yang", "url": "https://questionsmedicales.fr/author/Xia%20Yang", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, 530021, Nanning, Guangxi Zhuang Autonomous Region, China." } }, { "@type": "Person", "name": "Hirofumi Kurose", "url": "https://questionsmedicales.fr/author/Hirofumi%20Kurose", "affiliation": { "@type": "Organization", "name": "Department of Urology, Chikugo City Hospital, Chikugo, Japan." } }, { "@type": "Person", "name": "Keisuke Komiya", "url": "https://questionsmedicales.fr/author/Keisuke%20Komiya", "affiliation": { "@type": "Organization", "name": "Department of Urology, Kurume University School of Medicine, Kurume, Japan." } }, { "@type": "Person", "name": "Naoyuki Ogasawara", "url": "https://questionsmedicales.fr/author/Naoyuki%20Ogasawara", "affiliation": { "@type": "Organization", "name": "Department of Urology, Kurume University School of Medicine, Kurume, Japan." } }, { "@type": "Person", "name": "Kosuke Ueda", "url": "https://questionsmedicales.fr/author/Kosuke%20Ueda", "affiliation": { "@type": "Organization", "name": "Department of Urology, Kurume University School of Medicine, Kurume, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Iliac vein obstruction: accuracy of Direct Multidetector Computed Tomographic Venography and duplex ultrasound.", "datePublished": "2024-10-14", "url": "https://questionsmedicales.fr/article/39400315", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/bjr/tqae194" } }, { "@type": "ScholarlyArticle", "name": "A computational and machine learning approach to identify GPR40-targeting agonists for neurodegenerative disease treatment.", "datePublished": "2024-10-08", "url": "https://questionsmedicales.fr/article/39378198", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0306579" } }, { "@type": "ScholarlyArticle", "name": "Non-invasive physiological assessment of coronary artery obstruction on coronary computed tomography angiography.", "datePublished": "2024-10-07", "url": "https://questionsmedicales.fr/article/39373810", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12471-024-01902-7" } }, { "@type": "ScholarlyArticle", "name": "Enhancing human computer interaction with coot optimization and deep learning for multi language identification.", "datePublished": "2024-10-03", "url": "https://questionsmedicales.fr/article/39362948", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-74327-2" } }, { "@type": "ScholarlyArticle", "name": "Analysis of growth pattern of temporal bone pneumatization using 3D reconstructed computed tomography.", "datePublished": "2024-09-30", "url": "https://questionsmedicales.fr/article/39344435", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/02841851241281966" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes physiologiques", "item": "https://questionsmedicales.fr/mesh/D010829" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes pharmacologiques et toxicologiques", "item": "https://questionsmedicales.fr/mesh/D002620" }, { "@type": "ListItem", "position": 4, "name": "Phénomènes toxicologiques", "item": "https://questionsmedicales.fr/mesh/D000069436" }, { "@type": "ListItem", "position": 5, "name": "Relation dose-effet des médicaments", "item": "https://questionsmedicales.fr/mesh/D004305" }, { "@type": "ListItem", "position": 6, "name": "Dose létale 50", "item": "https://questionsmedicales.fr/mesh/D007928" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Dose létale 50 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Dose létale 50", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Dose létale 50", "description": "Comment évaluer la DL50 d'une substance ?\nQuels tests sont utilisés pour mesurer la DL50 ?\nLa DL50 est-elle la même pour tous les organismes ?\nQuels facteurs influencent la DL50 ?\nComment la DL50 est-elle utilisée en recherche ?", "url": "https://questionsmedicales.fr/mesh/D007928?mesh_terms=Computer+Security&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Dose létale 50", "description": "Quels symptômes indiquent une exposition à une DL50 ?\nLes symptômes varient selon la substance ?\nPeut-on prédire les symptômes d'une DL50 ?\nQuels sont les signes d'une intoxication aiguë ?\nComment reconnaître une intoxication par un produit chimique ?", "url": "https://questionsmedicales.fr/mesh/D007928?mesh_terms=Computer+Security&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Dose létale 50", "description": "Comment prévenir l'exposition à des substances toxiques ?\nQuelles sont les mesures de sécurité en laboratoire ?\nLes réglementations aident-elles à prévenir les intoxications ?\nComment éduquer sur les dangers des substances toxiques ?\nLes étiquettes de produits chimiques sont-elles importantes ?", "url": "https://questionsmedicales.fr/mesh/D007928?mesh_terms=Computer+Security&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Dose létale 50", "description": "Quel est le traitement d'une intoxication aiguë ?\nLes antidotes sont-ils toujours efficaces ?\nComment gérer une exposition à une DL50 ?\nQuels soins sont nécessaires après une exposition ?\nLa décontamination est-elle nécessaire ?", "url": "https://questionsmedicales.fr/mesh/D007928?mesh_terms=Computer+Security&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Dose létale 50", "description": "Quelles complications peuvent survenir après une intoxication ?\nLes effets à long terme sont possibles ?\nComment surveiller les complications post-intoxication ?\nLes complications varient-elles selon la substance ?\nQuels sont les risques de réexposition ?", "url": "https://questionsmedicales.fr/mesh/D007928?mesh_terms=Computer+Security&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Dose létale 50", "description": "Quels sont les facteurs de risque d'intoxication ?\nLes travailleurs sont-ils plus à risque ?\nComment l'âge influence-t-il le risque d'intoxication ?\nLes maladies préexistantes augmentent-elles le risque ?\nL'environnement joue-t-il un rôle dans l'intoxication ?", "url": "https://questionsmedicales.fr/mesh/D007928?mesh_terms=Computer+Security&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la DL50 d'une substance ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La DL50 est déterminée par des études sur des groupes d'animaux exposés à différentes doses." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour mesurer la DL50 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de toxicité aiguë, souvent sur rongeurs, sont utilisés pour mesurer la DL50." } }, { "@type": "Question", "name": "La DL50 est-elle la même pour tous les organismes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, la DL50 varie selon l'espèce, le sexe et l'âge des organismes testés." } }, { "@type": "Question", "name": "Quels facteurs influencent la DL50 ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La DL50 peut être influencée par la voie d'exposition, la durée et la sensibilité individuelle." } }, { "@type": "Question", "name": "Comment la DL50 est-elle utilisée en recherche ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elle est utilisée pour comparer la toxicité de différentes substances et établir des normes de sécurité." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition à une DL50 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des nausées, vomissements, convulsions et coma." } }, { "@type": "Question", "name": "Les symptômes varient selon la substance ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes dépendent de la nature de la substance toxique et de la dose." } }, { "@type": "Question", "name": "Peut-on prédire les symptômes d'une DL50 ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des modèles précliniques peuvent aider à prédire les symptômes, mais il y a des variations." } }, { "@type": "Question", "name": "Quels sont les signes d'une intoxication aiguë ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des troubles respiratoires, des douleurs abdominales et des troubles neurologiques." } }, { "@type": "Question", "name": "Comment reconnaître une intoxication par un produit chimique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La reconnaissance repose sur l'historique d'exposition et l'apparition rapide des symptômes." } }, { "@type": "Question", "name": "Comment prévenir l'exposition à des substances toxiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection, suivre les protocoles de sécurité et éduquer le personnel." } }, { "@type": "Question", "name": "Quelles sont les mesures de sécurité en laboratoire ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les mesures incluent l'utilisation de hottes, de gants et de formation sur les risques chimiques." } }, { "@type": "Question", "name": "Les réglementations aident-elles à prévenir les intoxications ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les réglementations sur l'utilisation des produits chimiques aident à réduire les risques." } }, { "@type": "Question", "name": "Comment éduquer sur les dangers des substances toxiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des formations régulières et des affichages d'information peuvent sensibiliser aux dangers." } }, { "@type": "Question", "name": "Les étiquettes de produits chimiques sont-elles importantes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles fournissent des informations essentielles sur les dangers et les mesures de sécurité." } }, { "@type": "Question", "name": "Quel est le traitement d'une intoxication aiguë ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'élimination de la substance, le soutien des fonctions vitales et des antidotes si disponibles." } }, { "@type": "Question", "name": "Les antidotes sont-ils toujours efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'efficacité des antidotes dépend de la substance et du moment de l'administration." } }, { "@type": "Question", "name": "Comment gérer une exposition à une DL50 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il faut contacter un centre antipoison et suivre les protocoles d'urgence appropriés." } }, { "@type": "Question", "name": "Quels soins sont nécessaires après une exposition ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des soins de soutien, une surveillance continue et des traitements spécifiques peuvent être nécessaires." } }, { "@type": "Question", "name": "La décontamination est-elle nécessaire ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la décontamination est souvent nécessaire pour réduire l'absorption de la substance toxique." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une intoxication ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions organiques, des troubles neurologiques et des infections." } }, { "@type": "Question", "name": "Les effets à long terme sont possibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines substances peuvent causer des effets à long terme, comme des cancers ou des troubles chroniques." } }, { "@type": "Question", "name": "Comment surveiller les complications post-intoxication ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une surveillance médicale régulière est nécessaire pour détecter les complications précoces." } }, { "@type": "Question", "name": "Les complications varient-elles selon la substance ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications dépendent de la nature de la substance et de la dose reçue." } }, { "@type": "Question", "name": "Quels sont les risques de réexposition ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La réexposition peut aggraver les complications et augmenter le risque de maladies chroniques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'intoxication ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le sexe, l'état de santé et l'environnement de travail." } }, { "@type": "Question", "name": "Les travailleurs sont-ils plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les travailleurs exposés à des produits chimiques sont souvent à risque accru d'intoxication." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le risque d'intoxication ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les jeunes enfants et les personnes âgées sont plus vulnérables aux effets toxiques." } }, { "@type": "Question", "name": "Les maladies préexistantes augmentent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies peuvent rendre les individus plus sensibles aux effets toxiques." } }, { "@type": "Question", "name": "L'environnement joue-t-il un rôle dans l'intoxication ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un environnement pollué ou des conditions de travail dangereuses augmentent le risque." } } ] } ] }

Sources (10000 au total)

Iliac vein obstruction: accuracy of Direct Multidetector Computed Tomographic Venography and duplex ultrasound.

To evaluate the accuracy of direct computed tomographic venography (DCTV) and duplex ultrasound (DUS) in the identification of iliac vein obstruction in highly symptomatic patients with severe chronic... this study involved patients who had advanced CVD (CEAP C3-6). All patients underwent DCTV, venous duplex scanning, and IVUS. The presence of iliac vein obstruction was detected, and degree of obstruc... of 94 patients with CVD, IVUS identified iliac vein obstruction in 55 (58.5%) patients (25.5% was grade 1, 27.3% was grade 2, 47.3% was grade 3). The sensitivity, specificity of DCTV in diagnosing obs... DUS is a reasonable initial imaging modality for the identification of significant iliac vein obstruction. DCTV provides an accurate reproducible imaging for accurate estimation needed for treatment p... Direct CT Venography provides accurate reproducible radiological information required for treatment planning of patients with Iliac vein obstruction including accurate assessment of site of obstructio...

A computational and machine learning approach to identify GPR40-targeting agonists for neurodegenerative disease treatment.

The G protein-coupled receptor 40 (GPR40) is known to exert a significant influence on neurogenesis and neurodevelopment within the central nervous system of both humans and rodents. Research findings...

Analysis of growth pattern of temporal bone pneumatization using 3D reconstructed computed tomography.

Temporal bone pneumatization (TBP) is influenced by age, sex, and race, and it seems to progress rapidly to puberty. However, the extent of TBP in childhood remains unclear.... To investigate the progression of TBP in children aged 1-18 years via three-dimensional (3D) reconstruction of high-resolution computed tomography (CT) images.... A total of 432 temporal bones of 216 individuals aged 1-18 years with well-pneumatized mastoid antra on both sides were included in this retrospective work. We created 18 age groups, each with six boy... The linear regression equations that considered age and volume for all cases (y... TBP in boys was greater than that of girls at adolescence. It was possible to identify the specific periods of significant variation in the degree of pneumatization of temporal bone....

Pulp calcification identification on cone beam computed tomography: an artificial intelligence pilot study.

This study aims to verify the effectiveness of a deep neural network (DNN) in automatically identifying pulp calcification on cone beam computed tomography (CBCT) images.... This study retrospectively analysed 150 CBCT images. Pulp calcification was identified and manually annotated by three endodontists with 10 years of experience. A DNN model based on the U-Net architec... The model achieved a sensitivity of 75.91 ± 2.84% in automatically identifying pulp calcification, with a specificity of 68.88 ± 2.35%, an accuracy of 72.78 ± 2.13%, and an AUC of 73.68 ± 3.09%. Accor... The results indicate that the proposed method shows promise for identifying pulp calcification on CBCT images. Future research aims to expand the dataset and refine the model, thereby enhancing its cl... Registration was performed on the Chinese Clinical Trial Registry ( https://www.chictr.org.cn/ ) (Registration number: ChiCTR2300077078, 27/10/2023) and National Medical Research Registry Information ...